# AnBio Therapeutics Ltd. — Form D

AnBio Therapeutics Ltd. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-13. The offering totals $60.9M, of which $60.9M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-10-13
- Form: D
- Accession: 0001887703-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $60.9M
- Amount sold: $60.9M
- Minimum investment: $200K
- Investors: 13
- Date of first sale: 2021-09-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-416641

## Issuer

- Name: AnBio Therapeutics Ltd.
- CIK: 0001887703
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2021
- Address: 777 THIRD AVENUE, SUITE 1704, NEW YORK, NY, 10017
- Phone: 212-466-6378

## Officers, directors & promoters (10)

| Name | Role | Location |
| --- | --- | --- |
| Ting Jia | Director | New York, NY |
| Xiaohang (Tony) Tong | Director | Zunyi, Guizhou, F4 |
| Junyuan Wang | Director | Beijing, F4 |
| Wei Xu | Director | VANCOUVER, A1 |
| Bing Yan | Director | Plainsboro, NJ |
| Lihua Zheng | Director | New York, NY |
| Zhengwei Zhu | Director | Shanghai, F4 |
| Junyuan Wang | Executive Officer | Beijing, F4 |
| Bing Yan | Executive Officer | Plainsboro, NJ |
| Lihua Zheng | Executive Officer | New York, NY |

## More

- [CIK 1887703 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1887703&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001887703-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.